https://pharmaphorum.com/news/bayer-reveals-phase-3-data-improved-mri-contrast-agent
Bayer reveals phase 3 data for improved MRI contrast agent | pharmaphorum
Bayer is close to filing a new MRI contrast agent that can reduce levels of gadolinium, which can have health and environmental consequences.
bayerrevealsphasedataimproved